Danaher Danaher Q1 Revenues Up 58 Percent The firm beat the consensus Wall Street estimate on the top line as its Life Sciences revenues grew 115 percent and its Diagnostics revenue rose 34 percent. Danaher Expects Q1 2021 Revenue Growth Above Previous Guidance The company said it expects revenue growth to be approximately 57 percent year over year and non-GAAP core revenue growth to be approximately 29 percent. Integrated DNA Technologies Acquires Swift Biosciences The acquisition is IDT's first since being bought by Danaher and is a departure from its previous acquisitions of oligo synthesis businesses. Danaher Q4 Revenues up 39 Percent The company's life sciences revenues grew 76 percent, while diagnostics revenues increased 24 percent. JP Morgan Healthcare Conference 2021, Day 3: Exact Sciences, Danaher, NanoString, Bio-Techne, More Exact Sciences discussed new Cologuard data; Danaher reviewed Cepheid's 2020 performance; and NanoString talked about forthcoming spatial biology products. Dec 23, 2020 People in the News: New Appointments at Danaher, Biological Dynamics, Omniome, and More Dec 18, 2020 People in the News: New Appointments at Fluidigm, Danaher, Guardant Health Oct 22, 2020 Danaher Q3 Revenues Up 35 Percent Sep 30, 2020 Danaher Prices $1B Senior Notes Offering Aug 27, 2020 As Abbott Stock Rises on EUA for Antigen Test, Competitors' Shares Take a Hit Aug 6, 2020 Genedrive, Beckman Coulter Life Sciences Partner on Automated PCR Testing for SARS-CoV-2 Jul 29, 2020 France's DNA Script Extends Series B Financing Round to $89M Jul 23, 2020 Danaher Q2 Revenues Spike 19 Percent Jul 17, 2020 Cepheid Debuts 10-Color Molecular Detection Technology With New Tuberculosis Test Premium Jun 10, 2020 Danaher Replaces Previous $5B Credit Facility with New $2.5B Facility May 26, 2020 Bio-Techne, Leica Biosystems Receive CE Mark for Pathology Detection Kit, Platform May 8, 2020 Danaher Stock Offerings to Raise $3B May 7, 2020 Danaher Q1 Revenues Up 3 Percent; Joyce Retiring as CEO Apr 13, 2020 Danaher Preliminary Q1 Revenues Grow 3 Percent; Firm Withdraws 2020 Guidance Mar 26, 2020 Danaher Prices €1.7 Billion Offering of Senior Notes Mar 21, 2020 Cepheid Coronavirus Assay First Point-of-Care Test to Get FDA Emergency Use Authorization Mar 3, 2020 Integrated DNA Technologies Authorized Under CDC EUA to Provide SARS-CoV-2 Test Kits Feb 12, 2020 Diagnostics Firms Rush to Develop Rapid Point-of-Care Tests for Novel Coronavirus Premium Jan 30, 2020 Danaher Q4 Revenues Climb 6 Percent Jan 15, 2020 JP Morgan Healthcare Day 2: 10x Genomics, GenapSys, Caris, Adaptive Bio, Danaher, Agilent, Luminex Load More Breaking News Sequencing Study Uncovers MERS-Related Coronavirus in Swiss Bats Angstrom Bio Raises $3M in Private Financing Eagle Biosciences, Genetic Analysis Ink Distribution Agreement for Gut Microbiota Test Centogene Q1 Revenues Grow More Than Fivefold Driven by COVID-19 Testing Epizyme Partnering With Quest Diagnostics for Lymphoma Mutation Testing Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel The Scan CDC Calls Delta "Variant of Concern" CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern." From FDA to Venture Capital Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post. Consent Questions Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles. Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.